Retatrutide, a experimental dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) target, is demonstrating promising results in preliminary clinical trials . Ongoing https://zanybookmarks.com/story21476561/retatrutide-emerging-research-and-possible-clinical-applications